EX-99.1 2 ir_ldmicrofinal.htm EX-99.1
ACNTNASDAQ LD Micro Invitational XVI May 17-19, 2026

Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties, including without limitation those identified below, which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements. The following factors could cause actual results to differ materially from historical results or those anticipated: adverse economic conditions, including risks relating to the impact and spread of and the government’s response to pandemics; inability to weather an economic downturn; the impact of competitive products and pricing; product demand and acceptance risks; raw material and other increased costs, including the impact of tariffs; raw material availability; financial stability of the Company’s customers; customer delays or difficulties in the production of products; loss of consumer or investor confidence; employee relations; ability to maintain workforce by hiring trained employees; labor efficiencies; risks associated with acquisitions; environmental issues; negative or unexpected results from tax law changes; inability to comply with covenants and ratios required by the Company’s debt financing arrangements; and other risks detailed from time-to-time in Ascent Industries Co.'s Securities and Exchange Commission filings, including our Annual Report on Form 10-K, which filings are available from the SEC. Ascent Industries Co. assumes no obligation to update any forward-looking information included in this release. Non-GAAP Financial Information Financial statement information included in this earnings release includes non-GAAP (Generally Accepted Accounting Principles) measures and should be read along with the accompanying tables which provide a reconciliation of non-GAAP measures to GAAP measures. Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense, income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, shelf registration costs, loss on extinguishment of debt, retention costs and restructuring & severance costs from net income. Management believes that these non-GAAP measures are useful because they are key measures used by our management team to evaluate our operating performance, generate future operating plans and make strategic decisions as well as allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP. Forward Looking Statement Safe Harbor and Non-GAAP Information 2

Kitchen, Kavalauskas, and many of their management team counterparts have previously worked together, a synergy that has had an undeniable impact on Ascent's operational and financial performance since assuming their roles in early 2024 CEO & CFO Have a Proven Track Record of Making Good Specialty Chemical Companies Great Bryan Kitchen President & Chief Executive Officer  Bryan joined Ascent in September 2023 to lead the specialty chemicals segment; promoted to president & CEO in February 2024  Prior to joining Ascent, Bryan led the stabilization, turnaround and successful sale of Clearon Corp to Solenis Previous experience: Ryan Kavalauskas Chief Financial Officer  Ryan joined Ascent as CFO in February 2024  Prior to joining Ascent, Ryan was the CFO at Clearon and played an instrumental role in the stabilization, turnaround and successful sale of Clearon Corp to Solenis Previous Experience: Built to deliver durable shareholder value. Led by those who’ve done it before, together.

After 75 years, we are going back to our roots as a Specialty Chemical Company Company Founded Blackman Uhler Industries, Inc. was founded in 1945, marking the company’s entry into the specialty chemical market. Bristol Metals Blackman Uhler Industries, Inc. acquired Bristol Metals, initiating the company's expansion into the stainless-steel industry and further diversifying its operations. Synalloy Corporation Blackman Uhler Industries Inc., changes name to Synalloy Corporation. Initial Public Offering Synalloy Corporation launched its initial public offering on the NASDAQ Stock Exchange, trading under the ticker symbol SYNL. Manufacturers Chemicals Synalloy Corporation acquires Manufacturers Chemicals, significantly expanding the company’s footprint in the specialty chemicals sector and diversifying its product offering Rite Industries Synalloy Corporation combined its textile dyes business with Rite Industries to form a new subsidiary, Blackman Uhler Specialties. Palmer of Texas Tanks Synalloy Corporation acquired Palmer of Texas Tanks, a premier manufacturer of fiberglass and stainless storage tanks used primarily in the oil industry. CRI Tolling In line with its long- term commitment to the chemical industry, Synalloy Corporation acquired CRI Tolling, marking its first foray into specialty chemical custom manufacturing. Specialty Pipe & Tube Synalloy Corporation advanced its vertical integration and expanded its metals business by acquiring Specialty Pipe & Tube and the U.S. assets of Marcegaglia in 2014. Marcegaglia USA Further expanding its metal business, in 2016, Synalloy Corporation acquired the stainless- steel pipe and tube assets of Marcegaglia USA. Marcegaglia USA Synalloy Corporation made yet another acquisition acquiring the galvanized pipe and tube assets of Marcegaglia USA. American Stainless Tubing, Inc. Synalloy Corporation further diversified through the acquisition of American Stainless Tubing Inc., a leading manufacturer of ornamental stainless- steel tubing. DanChem Technologies Expanding on its presence in specialty chemicals custom manufacturing, Synalloy Corporation acquired DanChem Technologies in 2021 from Edgewater Capital Partners. Ascent Industries Co. Synalloy Corporation rebranded to Ascent Industries Co., trading on the NASDAQ Stock Exchange under the ticker symbol ACNT. Divestiture of Specialty Pipe & Tube Executing against its strategic plan, Ascent sold the business and related assets of Specialty Pipe & Tube to a Financial Sponsor. Portfolio Optimization Ascent sells substantially all operating assets associated with the Tubular segment 1945 1964 1967 1980 1996 2003 2012 2013 2014 2016 2018 2019 2021 2022 2023 20252024 Management Turnaround Kitchen & Kavalauskas installed as CEO and CFO respectively; high- impact team was assembled to accelerate transformation and unlock shareholder value 3 Domestic Manufacturing Sites 5 Manufacturing Plants ~95% Revenue Supported With Domestic Raw Materials 1945 Founded ~192 Employees 170+ Customers $74.9M 2025 Revenue 4

Highlights Since Management Team Installed in 2024 $54M 11% Outstanding Shares Repurchased Jan. 1, 2025 – March 31, 2026 | 1.18M Shares $2.1M Annualized Cash Liberated via Munhall Lease Assignment Increase in TTM Adj. EBITDA TTM Increase / $4.1M; Adj. EBITDA Margin from -5.8% to -.8%88% Continuing Operations Performance Through 2025 Proceeds Generated Bristol & ASTI Asset Sale % Based on OS as of 12/31/2024 $10M Growth Program Win in Q42025 for 2026 Impact PR dated 12/1/2025 PR dated 11/17/2025 PR dated 4/7/2025 and 6/30/2025 Increase in TTM Adj. EBITDA TTM Increase / $8.2M100.2% Continuing Operations Performance Through Q32025 61 Increase in TTM Gross Profit TTM Increase / $6.5M; Gross Margin from 13.2% to 23% Continuing Operations Performance Through 2025 5

Pure-Play Who We Are, What We Do & How We Operate Specialty Chemicals Company

Life Sciences Performance Materials HI&I Personal Care Agriculture CASE Water Treatment Oil & Gas Pulp & Paper Where We Participate We deliver tailored specialty- chemistry solutions at scale across an array of high-value segments Textiles

Our Strategy & Operating Model O U TCO M E S OV E R E V E RY T H I N G . We’re building a platform that solves real problems across the value chain,not just by providing products or capacity, but by offering a full suite of services: formulation development,reaction capabilities,blending,packaging, logistics,regulatory support and reliable delivery.

THE CHALLENGE Unexpected supply disruption surfaced when a critical additive was discontinued. With no immediate replacement available, their drilling fluid system risked operational downtime and performance instability across active field operations. CUSTOM FORMULATION DEVELOPMENT Developed and evaluated three tailored formulation options optimized for the customer’s mud system, improving handling characteristics and blending compatibility. ACCELERATE SAMPLE DELIVERY Delivered qualified lab samples within three week, enabling rapid field evaluation. PILOT & COMMERCIAL VALIDATION Completed piloting and commercial validation of the selected formulation in just 30 days. RAPID COMMERCIAL LAUNCH Shipped the first commercial truckload within two months of the initial inquiry; qualified at (2) of Ascent’s manufacturing sites WE DELIVERED THE PROCESS 1. Research Conducted 2. Product Development in Lab 3. Customer Lab Qualification 4. Customer Field Qualification 5. Supply Agreement Executed Rapid Reformulation for Drilling Fluid Additive CASE STUDY PRODUCT SALES +$7M 2 mos.in WE SECURED Became a top 5 customer in 2025 Annualized Revenue Growth at Full Run- Rate From Initial Inquiry to First Purchase Order Customized Product Development

Complex Portfolio Transition Under Supply Risk THE CHALLENGE A global leader lost reliable manufacturing across 10+ heritage products with incomplete technical documentation and minimal transition pathways,creating immediate business risk. RAPID CROS S-F UNCTION MOBILIZATION Aligned R&D,Engineering,Operations,and Commercial teams immediately to stabilize supply under compressed timelines. FORMULATION RECONS TRUCTION & VALIDATION Rebuilt technical documentation,developed parallel formulation pathways,and executed accelerated lab and end-user testing. CONCURRENT MULTI-SITE SC A L E - UP Executed parallel trial campaigns across VA and SC,advancing structured batch validation and SOP development to accelerate commercialization. EXECUTION DISCIPLINE & SUPPLY RELIABILITY Achieved 100% OTIF performance while shortening lead times and restoring predictable supply to end users. WE DELIVERED Multiple 4,000 Gal Reactors REACTIONS & POLYMERIZATIONS Overheads w/ Receivers DISTILLATION Multiple Heated Storage Tanks STORAGE Accelerated Multi-Site Technology Transfer +$10M 6 mos.in WE SECURED Will Become a Top 5 Customer in 2026 Annualized Revenue Growth at Full Run- Rate From Initial Inquiry to First Purchase Order CASE STUDY CUSTOM MANUFACTURING MAIN EQUIPMENT USED

SOLUTIONS BUSINESS MODEL Primary Development Formulation Customization Scale-Up Reaction & Drying Blending, Milling & Dispersing Warehousing Logistics Regulatory Products Toll Custom Manufacturing Manufacturing Buy,Build & Operate ASCENT (CaaS Model) Chemical Manufacturers Toll Manufactures Custom Manufacturers Distributors Integrated Capabilities and Agile Business Models for Superior Customer Outcomes backed by 75Years of Chemical Manufacturing Expertise WhatWe Do Execute a customer-centric chemical supply chain model that fuses development,scale-up,manufacturing(small batch & continuous),compliance and distribution into a unified offering HowWeWin We connectwith customers theway theywant;when,where,and how they choose.Wewin across the Moments that Matter[Development, Contracting,Manufacturing & Fulfillment and Service]

45%55% Ample, underutilized capacity provides a capital-light, low-risk foundation for outsized growth Requiring minimal capital reinvestment to support growth (M USD) Danville, VA Fountain Inn, SC Cleveland, TN Within an asset base capable of supporting significant growth with minimal capital reinvestment $1.3 $1.6 $1.4 $1.7 2 0 2 2 2 0 2 3 2 0 2 4 2 0 2 5 12 U T I L I Z A T I O N A V A I L A B L E C A P A C I T Y

While filling the plants with higher margin business that is more predictable and reliable Portfolio Defined, Refined & Rebranded Improving Both Material Margin & Gross Margin 13 5.0% 13.2% 23.0% 46% 49% 55% 2 0 2 3 2 0 2 4 2 0 2 5 Gross Margin Material Margin Business Model (% of Revenue) 10% 27% 30% 90% 73% 70% 2 0 2 3 2 0 2 4 2 0 2 5 Product Sale Custom Mfg.

Growth With Current Customers Growth With New Customers P RO J EC T CO U N T 100 S A L E S C YC L E ( M O N T H S ) * 2.87 2025 Pipeline Conversion CO N V E R S I O N R AT E * * 18% QoQ Selling Project Pipeline Growth (M USD) Q12026 Q42025 Q32025 Q22025 Q12025 16% P RO J EC T W I N S ( R E V E N U E B A S I S ) 14 P RO J EC T W I N S ( R E V E N U E B A S I S ) By Business Model P RO D U C T S A L E S33% C U S T O M M A N U FAC T U R I N G*Calculated from initial customer engagement to receipt of first purchase order **Calculated as wins divided by all closed projects (won & lost) 84% 67% Driven by a Strong & Growing Selling Project Pipeline Underwritten by customer needs Designed entirely around the customer experience Delivered through technical expertise; scaled with discipline …Outcomes Over Everything 128% CAGR

Impact Investor Friendly Priorities & Actions Capital Allocation

And strong liquidity to support investor- friendly capital allocation priorities Every internal investment and acquisition is about accelerating progress, creating synergies that make sense, and delivering real, sustainable value. It's not only about size, it's about outcomes that matter, both strategically and operationally. Our goal is simple: to align every move with our mission and ensure it drives maximum impact for our shareholders. Financial Profile: $5-150MM Revenue | $0-$25MM EBITDA Investment Type: Private or Publicly Held Asset Types: Specialty Chemicals Manufacturing, Distribution, Product Lines & Brands and Co-Packagers M&A Investment Focus $0 $39.2M * D E B T C A P A C I T Y ~$30M C A P A C I T Y T O I N V E S T ~$69.2M+ + = D E B T C A S H 16 Capital Allocation Active, but Disciplined1. Fund high-ROIC organic growth (top priority). We will underwrite projects where ROIC > WACC and where incremental FCF aligns with the DCF trajectory. 2. Selective, discipline M&A. Accretive on ROIC and FCF per share within a 3–5 year window; avoid growth that dilutes FCF/ROIC just to increase scale. 3. Share repurchases as a flexible, valuation-sensitive tool. Use when shares trade meaningfully below intrinsic value. Avoid growth that dilutes FCF/ROIC just to increase scale Repurchased 11% of Outstanding Shares Q12025-Q12026 % Based on OS as of 12/31/2024 *Inclusive of Escrow

First Acquisition by Current Management

PRIMARY SYNERGIES INSOURCING Absorb production into underutilized assets STRATEGIC SOURCING Leverage scale to improve raw material economics COMMERCIAL EXPANSION Cross-selling Ascent portfolio; unleash innovation & growth project pipeline Converts underutilized capacity into margin while unlocking growth that was not achievable at Midwest’s standalone scale S T R AT EG I C O U T CO M E Platform-Driven Growth Unlocks revenue expansion by scaling Midwest’s offerings through Ascent’s platform, capabilities,and customer reach Improved Asset Utilization Customized, customer- and application- specific products we can insource into underutilized assets, driving operating leverage and margin expansion Strategic Fit (CaaS) Direct alignment with our CaaS strategy; expands formulation capabilities,deepens CASE participation, and enables cross- portfolio cross-selling Durable,Embedded Demand Long-tenured customer relationships with high switching costs,supporting recurring revenue and earnings stability Execution-Driven Upside Value supported by current earnings, with incremental upside from strategic sourcing,vertical integration,and customer expansion, not required to justify the base case Revenue & Innovation Continuity Retention of key commercial leadership preserves customer relationships, pipeline,and product development - protecting and extending the growth trajectory W H Y T H I S C R E AT E S VA L U E Acquisition of Midwest Graphic Sales & Sigma Coatings A 40+ year family-owned innovator and specialty formulator of customized coatings for high-value packaging, food- service, and consumer applications Transaction Overview $1.05 MM ESCROW HELD FOR 18 MONTHS 7.5% $14.00 MM PURCHASE PRICE Transaction Summary $12.95 MM CASH AT CLOSE 92.5% Pre NWC-Adjustment Pre NWC-Adjustment

19 Printed Materials Visual Impact | Surface Protection | Tactile Finishes Beverage Packaging Package Integrity | Abrasion Resistance Food Contact Products Structural Integrity | FDA Compliant | Sustainability Playing Cards Slip | Durability | Handling Midwest’s coatings are engineered for high-performance playing cards, including use in the only cards approved for the World Series of Poker. These coatings deliver a precise balance of slip and durability, ensuring smooth handling, controlled shuffling, and long- term performance. Critically, they provide strong resistance to marking, scratching, and surface wear, preserving game integrity and preventing any visual or tactile inconsistencies that could impact play. CUSTOMIZED COATINGS FOR HIGH-VALUE PACKAGING, FOOD-SERVICE, AND CONSUMER APPLICATIONS Midwest’s coatings for food-contact paper products provide effective grease and water resistance, preventing soak-through and maintaining structural integrity during use. Additionally, these coatings are designed to meet FDA compliance requirements, ensuring safe use in direct food contact applications. They are engineered for efficient processing, enabling clean release from plate molds and supporting high-speed forming operations. Midwest’s coatings play a critical role in protecting beverage packaging that is routinely exposed to moisture from refrigeration, condensation, and handling. These coatings create a durable barrier that resists water intrusion, helping maintain package integrity and print quality in demanding retail environments. At the same time, they provide strong abrasion resistance, minimizing scuffing and scratching during transport, stocking, and consumer handling. Midwest’s coatings enhance the visual impact of printed materials by improving gloss, color depth, and image clarity, helping brands stand out on the shelf. They also provide critical surface protection, increasing resistance to scuffing, scratching, and handling throughout distribution. Tailored to deliver specific tactile finishes, such as soft-touch or matte, elevating the overall quality and consumer experience.

Financial Overview $16.72 MM INTRINSIC VALUE $2.07 ADJ. EBITDA (2025A) 6.8x ENTRY MULTIPLE Entry Economics $1.05 MM ESCROW Held for 18 Months 7.5% $14.00 MM PURCHASE PRICE Transaction Summary $12.95 MM CASH AT CLOSE 92.5% Tr ansaction is Under wr itten By: Existing Earnings Quality Demonstrated Margin Profile Durable, Embedded Business Model 16% IRR EXTERNAL SPEND Zero Bankers; Minimal Outside Legal Counsel, limited Q0E. Excludes PPA work or tax work as part of post closing integration. $20K Est. 20 20 MM 2025 AMetric $10.8MMRevenue $2.68MMGross Profit 24.7%Gross Margin $2.07MMAdj. EBITDA 19.1%Adj. EBITDA Margin 2025 Unaudited Financials Pre NWC-Adjustment Pre NWC-Adjustment

2026-2030 Durable Earnings-Growth The Path Forward

Simple and Clear EBITDA Drivers Management Turnaround  Structural cost savings with emphasis on strategic sourcing  Aggressive management of controllable spend  Discipline execution of overall equipment effectiveness (OEE)  Optimization of work processes & tools Organic Growth / Operating Leverage  Enhanced commercial strategy to grow share of higher- margin products  Increase plant utilization  Improve fixed cost absorption 2023 ADJ. EBITDA* % 2030 Continuing Operations ADJ. EBITDA Mgmt. Turnaround in 2024/2025 Organic Growth / Operating Leverage Inorganic Growth 22 Completed & Achieved Inorganic Growth  Searching for good businesses to make great  Leverage market and operational experience to unlock growth  Targeting $5-150M revenue and $0-$25M EBITDA * Adj. EBITDA represents the standalone Chemical segment excluding Corporate Overhead 4% 3% 15% U ps id e 8%

Why Invest in Ascent? Portfolio Optimized Strategic clarity. Focus. Efficiency. Stabilized and Growth Ready Predictability. Confidence. Credibility. Reduced risk. Growth Capacity In-Place Optionality. Scale. Margin. Growth. Resilience. Near-Term Upside Undervalued, leverage multiple upside. Strong Balance Sheet Stability. Strategic firepower for earnings-accretive M&A. Under-covered & Under Valued Early discovery can drive outsized investment returns when larger pools of capital follow. ……the right people, proven together, trusted by each other, and aligned to win the next phase

Investor Relations investorrelations@ascentco.com

Appendix

Reconciliations of Non- GAAP Adjusted EBITDA Financials Consolidated EBITDA and Adjusted EBITDA from Continuing Operations: Specialty Chemicals EBITDA and Adjusted EBITDA: 26 Three Months Ended March 31, ($ in thousands) 2026 2025 Consolidated Net loss from continuing operations $ (1,980) $ (2,006) Adjustments: Interest expense (income), net (294) 114 Income taxes 114 — Depreciation 861 978 Amortization 117 153 EBITDA (1,182) (761) Acquisition costs and other — 237 Shelf registration costs 14 — Stock-based compensation 134 35 Non-cash lease expense (26) 24 Restructuring and severance cost 97 — Adjusted EBITDA $ (963) $ (465) % of sales (5.0) % (2.6) % Three Months Ended March 31, ($ in thousands) 2026 2025 Specialty Chemicals Net income (loss) $ (2,142) $ 738 Adjustments: Interest expense, net 12 16 Depreciation 817 962 Amortization 117 153 EBITDA (1,196) 1,869 Acquisition costs and other — 92 Stock-based compensation 30 — Non-cash lease expense (15) 9 Restructuring and severance costs 38 — Specialty Chemicals Adjusted EBITDA $ (1,143) $ 1,970 % of segment sales (5.9) % 11.0 %